The medical morphine market is expected to gain growth at a potential rate of 8.00% in the forecast period of 2021 to 2028 and is expected to reach a value of USD 34.87 billion by 2028. The increase in the cases of arthritis among the young as well as old population is the factors for the market growth.
Global Medical Morphine Market Scope and Market Size
Based on route of administration, the medical morphine market is segmented into oral, injectables and others.
Based on application, the medical morphine market is segmented into arthritis, cancer, myocardial infarction, kidney stones, diarrhoea and others.
The medical morphine market is also segmented on the basis of end users into hospitals and clinics, ambulatory surgical centers, homecare and others.
On the basis of distribution channel, the medical morphine market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.
Click Here to Get Latest Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-morphine-market
Medical Morphine Market Country Level Analysis
The countries covered in the medical morphine market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
Medical Morphine Market Share Analysis
The medical morphine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to medical morphine market.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-medical-morphine-market
Key Players –
The major players covered in the medical morphine market report are Mallinckrodt Pharmaceuticals, Alcaliber S.A, Sanofi, Johnson Matthey, Northeast Pharmaceutical Group Co., Ltd, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Cipla Inc., Mylan N.V., Fresenius Kabi USA, DAIICHI SANKYO COMPANY, Allergan, Pacira BioSciences, Inc., Endo Pharmaceuticals Inc., Tris Pharma, Inc, Purdue Pharma L.P., VERVE HEALTH CARE LTD., Taj Pharmaceuticals Limited and AbbVie Inc., among other domestic and global players.
MAJOR TOC OF THE REPORT
Part One: Medical Morphine Market Overview
Part Two: Manufacturers Profiles
Part Three: Global Medical Morphine Market Competition, by Players
Part Four: Global Medical Morphine Market Size by Regions
Part Five: Global Medical Morphine Market Revenue by Countries
Part Six: Global Medical Morphine Market Revenue by Type
Part Seven: Global Medical Morphine Market Revenue by Application
Part Eight: Global Medical Morphine Market Revenue by Geography
Part Nine: Global Medical Morphine Market Revenue by Geography
Part Ten: Global Medical Morphine Market Revenue by Geography
Part Eleven: Global Medical Morphine Market Revenue by Geography
Get Detail TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-medical-morphine-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports@
Global Pleural Effusion Drug Market
Global Morphine Market: By Dosage Form (Injection, Oral), By Application (Pain Management, Diarrhea Suppressant, Cold Suppressant), By End User (Hospitals& Clinics, Ambulatory Surgical Centers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region (North America, Europe, Asia-Pacific, Rest of the World)—Forecast to 2027Medical Morphine Market-OverviewThe alarming rise in pain-related discomfort cases triggered by the onset of serious ailments is likely to spur the medical morphine market in 2020.
Also, the development of effective drug combinations is estimated to prompt the development of the medical morphine market size in the approaching period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10643 Segmental Analysis The segmental scrutiny of the medical morphine market has been conducted on the basis of application, route of administration, end-user, distribution channel, and region.
On the basis of end-user, the medical morphine market is segmented into home care, ambulatory surgical centers, and hospitals & clinics.
On the basis of application, the medical morphine market is segmented into myocardial infarction, arthritis, kidney stones, cancer, diarrhea, and others.
The Americas region held the principal share of the medical morphine market in 2017.
The European region is the next largest market and is anticipated will have a strong part in the medical morphine market in the forecast period.
Adroit Market Research launched a study titled, “Global Medical Morphine Market Size 2018 By Indication (Cancer, Arthritis, and Others), By Route of Administration (Injectables, Oral, and Others), By Region and Forecast 2018 to 2025”.
Furthermore, researchers at the University of Washington have developed a smartphone application named as Second Chances which is still in trials features opioid overdose detection.
Such advancements are expected to reduce the opioid crisis within the U.S. encouraging medical use of morphine.In terms of indication, others segment dominated the global medical morphine market pertaining to a large number of prescriptions of morphine for nominal medical conditions such as body pain, migraine, and many others within the U.S. which consumes more than 50% morphine globally.Browse complete report at: https://adroitmarketresearch.com/industry-reports/medical-morphine-marketGlobal Medical Morphine Market Share, by Route of Indication, 2025 (%)In terms of region, North America dominated the global market and is expected to do so in the coming years pertaining to rising consumption and abundant availability of the drug within the country.
Both the countries ranked in the top 5 globally.The global medical morphine market is characterized by consolidation on account of the highly regulated nature of production as well as the supply of raw materials majorly opium.
Currently, the shortage of injectable morphine was observed within the U.S.
Key vendors within the market include Mallinckrodt Pharmaceuticals, Johnson Matthey Fine Chemicals, Taj Pharmaceuticals Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and many more.Key segments of the global medical morphine marketIndication Overview, 2015-2025 (USD Million)CancerArthritisOthersRoute of Administration Overview, 2015-2025 (USD Million)OralInjectableOthersRegional Overview, 2015-2025 (USD Million)North AmericaS.EuropeGermanyAsia-PacificChinaIndiaRest of the WorldEnquire for buying Global Medical Morphine Market Report at: https://adroitmarketresearch.com/contacts/enquiry-before-buying/809About Us:Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the morphine hydrochloride market include Mallinckrodt Pharmaceuticals, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Allergan inc., Sandoz Canada Inc., Mayne Pharma Group Limited, Daiichi Sankyo Inc., Hikma Pharmaceuticals USA Inc.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Morphine Hydrochloride Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/morphine-hydrochloride-market/download-sampleMarket DynamicsMorphine hydrochloride is a narcotic analgesic widely used in pain control for cancer and trauma patients.
An increasing number of cancer and trauma patients are undergoing treatment due to expanding and improving healthcare infrastructure and accessible healthcare insurance service facilities and claiming processes.
In addition, many hospital pharmacists prefer morphine solutions because of their wide availability commercially.
However, severe side effects of morphine hydrochloride like respiratory depression, allergic reaction, bowel blockage, fast, slow or irregular heartbeat, and low blood pressure are likely to hinder its adoption for pain management, restraining market growth.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
